An Updated Review of Implantable Cardioverter/Defibrillators, Induced Anxiety, and Quality of Life

Heart Failure Clinics

Volumn 7, Issue 1, 2011, Pages 101-108

  Bostwick, J Michael ^a   Sola, Christopher L ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Anxiety; Depression; Psychopathology

Indexed keywords

BENZODIAZEPINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY DISORDER; AVOIDANCE BEHAVIOR; COGNITIVE THERAPY; CORRELATION ANALYSIS; DEFIBRILLATOR; FAMILY ATTITUDE; GROUPS BY AGE; HUMAN; JUVENILE; MENTAL DISEASE; OPTIMISM; PSYCHOEDUCATION; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SHOCK WAVE; SUPPORT GROUP;

EID: 78649393682     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2010.10.003     Document Type: Review

References (58)

1. DiMarco J.P. Implantable cardioverter-defibrillators. N Engl J Med 2003, 349(19):1836-1847.
2. Glikson M., Friedman P.A. The implantable cardioverter defibrillator. Lancet 2001, 357(9262):1107-1117.
3. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996, 335(26):1933-1940.
4. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997, 337(22):1576-1583.
5. Connolly S.J., Gent M., Roberts R.S., et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000, 101(11):1297-1302.
6. Kuck K.H., Cappato R., Siebels J., et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000, 102(7):748-754.
7. Bokhari F., Newman D., Greene M., et al. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation 2004, 110(2):112-116.
8. Greenberg H., Case R.B., Moss A.J., et al. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004, 43(8):1459-1465.
9. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352(3):225-237.
10. U.S. Food and Drug Administration Center for Devices and Radiological Health. Available at: Accessed June 8, 2007. http://www.accessdata.fda.gov/scripts/cdrh/devicesatfda/index.cfm.
11. Vlay S.C. The automatic internal cardioverter-defibrillator: comprehensive clinical follow-up, economic and social impact-the Stony Brook experience. Am Heart J 1986, 112(1):189-194.
12. Luderitz B., Jung W., Deister A., et al. Patient acceptance of the implantable cardioverter defibrillator in ventricular tachyarrhythmias. Pacing Clin Electrophysiol 1993, 16(9):1815-1821.
13. Eads A.S., Sears S.F., Sotile W.M., et al. Supportive communication with implantable cardioverter defibrillator patients: seven principles to facilitate psychosocial adjustment. J Cardiopulm Rehabil 2000, 20(2):109-114.
14. Kuhl E.A., Dixit N.K., Walker R.L., et al. Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale. Pacing Clin Electrophysiol 2006, 29(6):614-618.
15. Kamphuis H.C., de Leeuw J.R., Derksen R., et al. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Europace 2003, 5(4):381-389.
16. Namerow P.B., Firth B.R., Heywood G.M., et al. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG Patch Trial. Pacing Clin Electrophysiol 1999, 22(9):1305-1313.
17. Irvine J., Dorian P., Baker B., et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002, 144(2):282-289.
18. Sears S.E., Conti J.B. Understanding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care. Clin Cardiol 2003, 26(3):107-111.
19. Sola C.L., Bostwick J.M. Implantable cardioverter-defibrillators, induced anxiety, and quality of life. Mayo Clin Proc 2005, 80(2):232-237.
20. DeMaso D.R., Lauretti A., Spieth L., et al. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am J Cardiol 2004, 93(5):582-587.
21. Crossmann A., Pauli P., Dengler W., et al. Stability and cause of anxiety in patients with an implantable cardioverter-defibrillator: a longitudinal two-year follow-up. Heart Lung 2007, 36(2):87-95.
22. Bilge A.K., Ozben B., Demircan S., et al. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin Electrophysiol 2006, 29(6):619-626.
23. Yarnoz M.J., Curtis A.B. Why cardioverter-defibrillator implantation might not be the best idea for your elderly patient. Am J Geriatr Cardiol 2006, 15(6):367-371.
24. Hamilton G.A., Carroll D.L. The effects of age on quality of life in implantable cardioverter defibrillator recipients. J Clin Nurs 2004, 13(2):194-200.
25. Thomas S.A., Friedmann E., Kao C.W., et al. Quality of life and psychological status of patients with implantable cardioverter defibrillators. Am J Crit Care 2006, 15(4):389-398.
26. Walker R.L., Campbell K.A., Sears S.F., et al. Women and the implantable cardioverter defibrillator: a lifespan perspective on key psychosocial issues. Clin Cardiol 2004, 27(10):543-546.
27. Sowell L.V., Kuhl E.A., Sears S.F., et al. Device implant technique and consideration of body image: specific procedures for implantable cardioverter defibrillators in female patients. J Womens Health (Larchmt) 2006, 15(7):830-835.
28. Luyster F.S., Hughes J.W., Waechter D., et al. Resource loss predicts depression and anxiety among patients treated with an implantable cardioverter defibrillator. Psychosom Med 2006, 68(5):794-800.
29. Smith G., Dunbar S.B., Valderrama A.L., et al. Gender differences in implantable cardioverter-defibrillator patients at the time of insertion. Prog Cardiovasc Nurs 2006, 21(2):76-82.
30. Bourke J.P., Turkington D., Thomas G., et al. Florid psychopathology in patients receiving shocks from implanted cardioverter-defibrillators. Heart 1997, 78(6):581-583.
31. Leosdottir M., Sigurdsson E., Reimarsdottir G., et al. Health-related quality of life of patients with implantable cardioverter defibrillators compared with that of pacemaker recipients. Europace 2006, 8(3):168-174.
32. Godemann F., Butter C., Lampe F., et al. Determinants of the quality of life (QoL) in patients with an implantable cardioverter/defibrillator (ICD). Qual Life Res 2004, 13(2):411-416.
33. Newall E.G., Lever N.A., Prasad S., et al. Psychological implications of ICD implantation in a New Zealand population. Europace 2007, 9(1):20-24.
34. Sears S.F., Lewis T.S., Kuhl E.A., et al. Predictors of quality of life in patients with implantable cardioverter defibrillators. Psychosomatics 2005, 46(5):451-457.
35. Pedersen S.S., van Domburg R.T., Theuns D.A., et al. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J 2005, 149(4):664-669.
36. Prudente L.A., Reigle J., Bourguignon C., et al. Psychological indices and phantom shocks in patients with ICD. J Interv Card Electrophysiol 2006, 15(3):185-190.
37. Hoecksel K., Bostwick J. Getting to the heart of his shocking trauma. Current Psychiatry 2007, 6:84-91.
38. Steinke E.E., Gill-Hopple K., Valdez D., et al. Sexual concerns and educational needs after an implantable cardioverter defibrillator. Heart Lung 2005, 34(5):299-308.
39. Sears S.F., Stutts L.A., Aranda J.M., et al. Managing congestive heart failure patient factors in the device era. Congest Heart Fail 2006, 12(6):335-340.
40. Lemon J., Edelman S., Kirkness A. Avoidance behaviors in patients with implantable cardioverter defibrillators. Heart Lung 2004, 33(3):176-182.
41. Burg M.M., Lampert R., Joska T., et al. Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias. Psychosom Med 2004, 66(6):898-902.
42. Lemon J., Edelman S. Psychological adaptation to ICDs and the influence of anxiety sensitivity. Psychol Health Med 2007, 12(2):163-171.
43. Sears S.F., Serber E.R., Lewis T.S., et al. Do positive health expectations and optimism relate to quality-of-life outcomes for the patient with an implantable cardioverter defibrillator?. J Cardiopulm Rehabil 2004, 24(5):324-331.
44. Dougherty C.M., Lewis F.M., Thompson E.A., et al. Short-term efficacy of a telephone intervention by expert nurses after an implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004, 27(12):1594-1602.
45. Sears S.F., Shea J.B., Conti J.B. Cardiology patient page. How to respond to an implantable cardioverter-defibrillator shock. Circulation 2005, 111(23):e380-e382.
46. Prudente L.A. Psychological disturbances, adjustment, and the development of phantom shocks in patients with an implantable cardioverter defibrillator. J Cardiovasc Nurs 2005, 20(4):288-293.
47. Kuhl E.A., Sears S.F., Conti J.B. Using computers to improve the psychosocial care of implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol 2006, 29(12):1426-1433.
48. The Zapper online newsletter. Available at: Accessed June 8, 2007. http://www.zaplife.org/.
49. Johnson B, Francis J. Cognitive behavourial therapy for patients with implantable cardioverter-defibrillators [protocol]. The Cochrane Library, Issue 3, 2007. Available at: Accessed May 29, 2007. http://www.thecochranelibrary.com.
50. Chevalier P., Cottraux J., Mollard E., et al. Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial. Am Heart J 2006, 151(1). 191, e1-191.e6.
51. Frizelle D.J., Lewin R.J., Kaye G., et al. Cognitive-behavioural rehabilitation programme for patients with an implanted cardioverter defibrillator: a pilot study. Br J Health Psychol 2004, 9(Pt 3):381-392.
52. Belardinelli R., Capestro F., Misiani A., et al. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy. Eur J Cardiovasc Prev Rehabil 2006, 13(5):818-825.
53. Carnes C.A., Pickworth K.K., Votolato N.A., et al. Elevated defibrillation threshold with venlafaxine therapy. Pharmacotherapy 2004, 24(8):1095-1098.
54. Stutts L.A., Cross N.J., Conti J.B., et al. Examination of research trends on patient factors in patients with implantable cardioverter defibrillators. Clin Cardiol 2007, 30(2):64-68.
55. Sears S.F., Conti J.B. Psychological aspects of cardiac devices and recalls in patients with implantable cardioverter defibrillators. Am J Cardiol 2006, 98(4):565-567.
56. van den Broek K.C., Denollet J., Nyklicek I., et al. Psychological reaction to potential malfunctioning of implantable defibrillators. Pacing Clin Electrophysiol 2006, 29(9):953-956.
57. Noyes K., Corona E., Zwanziger J., et al. Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II. Med Care 2007, 45(5):377-385.
58. Frizelle D.J., Lewin B., Kaye G., et al. Development of a measure of the concerns held by people with implanted cardioverter defibrillators: the ICDC. Br J Health Psychol 2006, 11(Pt 2):293-301.